UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000015568 |
|---|---|
| Receipt number | R000018092 |
| Scientific Title | Phase II study of EGFR-TKI rechallenge with afatinib in advanced NSCLC patients haboring sensitive EGFR mutation without T790M |
| Date of disclosure of the study information | 2014/11/30 |
| Last modified on | 2019/02/10 09:31:00 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2014/10/30 17:33:45 | ||
| 2 | Update | 2014/11/07 01:10:48 | Key inclusion criteria Key exclusion criteria |
|
| 3 | Update | 2014/11/18 23:13:48 | Key inclusion criteria |
|
| 4 | Update | 2015/06/01 11:19:41 | Recruitment status |
|
| 5 | Update | 2015/06/28 13:22:33 | Email Email1 |
|
| 6 | Update | 2016/01/21 22:56:21 | Email1 |
|
| 7 | Update | 2017/06/29 12:50:47 | Recruitment status |
|
| 8 | Update | 2017/06/29 12:52:18 | Name of primary person or sponsor Organization |
|
| 9 | Update | 2019/02/10 09:31:00 | Recruitment status Publication of results |
